Ascendis Pharma A/S vs Workiva Inc — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Workiva Inc trades at $68.63 (market cap $3.76B). The key difference: Ascendis Pharma A/S is far larger — about 4.4× Workiva Inc's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Workiva Inc nearer its low. Which is the better fit depends on your goals.
| ASND | WK | |
|---|---|---|
Market Cap | $16.67B | $3.76B |
Sector | Health | Technology |
52-Week High | $277.18 | $93.31 |
52-Week Low | $189.74 | $44.31 |
Enterprise Value | $17.04B | $3.73B |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Workiva is a leading provider of cloud-based platforms for complex reporting and compliance. It enables organizations to connect and manage data across financial reporting, ESG (Environmental, Social, and Governance), and GRC (Governance, Risk, and Compliance), serving as a single source of truth for auditable, transparent disclosures to regulators and stakeholders.
Read more on WK →